Assessment of the quality of life after discharge from the ICU: a comparison of COVID-19 and non-COVID-19 patients

Journal title SALUTE E SOCIETÀ
Author/s Vincenzo Auriemma, Ivana Ferrara, Ester Miranda, Salvatore Patti, Daniela Baldassarre, Giuliana Scarpati, Gennaro Iorio, Ornella Piazza
Publishing Year 2025 Issue 2025/1
Language English Pages 12 P. 145-156 File size 291 KB
DOI 10.3280/SES2025-001010
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Background: The World Health Organization (WHO) has declared that the COVID-19 pandemic has had a serious impact on the mental health and well-being of people worldwide. Method: The authors conducted an observational pilot study, considering two patient cohorts: the first sample of 20 non-COVID-19 patients admitted to the ICU from September 2019 to September 2020 and the second sample of 26 COVID-19 patients admitted to the ICU from October 2020 and April 2021. Participants were contacted for a telephone interview within six months after discharge. Results: The quality of life, calculated through the SF-12, of patients admitted for COVID- 19 in 2020-21 is worse than the sample discharged from the ICU in the previous period, 2019-2020. Conclusions: The quality of life indices that emerged in both the pandemic and prepandemic eras were lower than average, but when comparing the two cohorts, the indices collected in the pandemic era were lower.

Keywords: quality of life; COVID-19; intensive care; questionnaire SF-12; comparative research; post-COVID-19.

  1. Balasubramanian A., Paleri V., Bennett R., Paleri V. (2020). Impact of COVID-19 on the mental health of surgeons and coping strategies. Head Neck, 42(7): 1638-1644.
  2. Bellan M., Baricich A., Patrucco F. et al. (2021). Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep, 11(1): 22666.
  3. Bloomer M.J., Bouchoucha S. (2020). Editorial: COVID-19 and what it means for end-of-life care in ICU: Balancing the priorities. Collegian, 27(3): 248–249.
  4. Counts N.Z., Staglin B., Rosenberg L. (2020). Mental Health for US. The Lancet Psychiatry, 7(4): 299-300. DOI: 10.1016/S2215-0366(19)30377-
  5. Hayes L.D., Ingram J., Sculthorpe N.F. (2021). More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Frontiers in Medicine, 8:750378.
  6. Huang C., Huang L., Wang Y. et al. (2023). Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England), 401(10393) DOI: 10.1016/S01406736(23)01175-
  7. ISTAT DATA (2020). Stato di Salute. -- https://www.istat.it/it/files/2011/02/metadati.pdf (10/05/2021).
  8. Levkovich I., Shinan-Altman S. (2021). Impact of the COVID-19 pandemic on stress and emotional reactions in Israel: a mixed-methods study. International Health, 13(4), pp. 358–366.
  9. Li J., Xia W., Zhan C. et al. (2022). A telerehabilitation programme in postdischarge COVID-19 patients (TERECO): A randomised controlled trial. Thorax, 77(7): 697–706.
  10. Marconi M. (2020). Differenze di genere in COVID-19: l’importanza dei dati disaggregati per sesso. EpiCentro, ISS. -- Testo disponibile al sito: https://www.epicentro.iss.it/coronavirus/sars-cov-2-differenze-genere- importanza-dati-disaggregati (23/06/2022)
  11. Martino M., Aboud N., Cola M.F. et al. (2021). Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: The CORTICOVID study. J Endocrinol Invest., 44(5): 1075-1084.
  12. Ortolan A., Lorenzin M., Felicetti M., Doria A., Ramonda R. (2020). Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. International Journal of Infectious Diseases, 99: 496-504.
  13. RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 397(10285): 1637-1645. DOI: 10.1016/S01406736(21)00676-
  14. Rivi V., Melegari G., Blom J.M.C. (2021). How to humanise the COVID-19 intensive care units. BMJ Evidence-Based Medicine, 26(4): 141-142.
  15. Salvarani C., Dolci G., Massari M. et al. (2021). Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial. JAMA Internal Medicine, 181(1): 24-31.

Vincenzo Auriemma, Ivana Ferrara, Ester Miranda, Salvatore Patti, Daniela Baldassarre, Giuliana Scarpati, Gennaro Iorio, Ornella Piazza, Assessment of the quality of life after discharge from the ICU: a comparison of COVID-19 and non-COVID-19 patients in "SALUTE E SOCIETÀ" 1/2025, pp 145-156, DOI: 10.3280/SES2025-001010